{"id":"https://openalex.org/W2912404136","doi":"https://doi.org/10.1016/j.diabet.2019.01.006","title":"Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings","display_name":"Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings","publication_year":2019,"publication_date":"2019-01-21","ids":{"openalex":"https://openalex.org/W2912404136","doi":"https://doi.org/10.1016/j.diabet.2019.01.006","mag":"2912404136","pmid":"https://pubmed.ncbi.nlm.nih.gov/30677504"},"language":"en","primary_location":{"id":"doi:10.1016/j.diabet.2019.01.006","doi":"https://doi.org/10.1016/j.diabet.2019.01.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabet.2019.01.006","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S1262363619300217?via%3Dihub","source":{"id":"https://openalex.org/S49871393","display_name":"Diabetes & Metabolism","issn_l":"1262-3636","issn":["1262-3636","1878-1780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Diabetes & Metabolism","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/am/pii/S1262363619300217?via%3Dihub","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064287355","display_name":"Bruno Guerci","orcid":"https://orcid.org/0000-0002-6211-464X","observed_orcids":["https://orcid.org/0000-0002-6211-464X"]},"institutions":[{"id":"https://openalex.org/I90183372","display_name":"Universit\u00e9 de Lorraine","ror":"https://ror.org/04vfs2w97","country_code":"FR","type":"education","lineage":["https://openalex.org/I90183372"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"B. Guerci","raw_affiliation_strings":["Department of endocrinology, diabetology, and nutrition, Brabois hospital and university of Lorraine, 54500 Vand\u0153uvre-l\u00e8s-Nancy, France. Electronic address: b.guerci@chu-nancy.fr","Department of endocrinology, diabetology, and nutrition, Brabois hospital and university of Lorraine, 54500 Vand\u0153uvre-l\u00e8s-Nancy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of endocrinology, diabetology, and nutrition, Brabois hospital and university of Lorraine, 54500 Vand\u0153uvre-l\u00e8s-Nancy, France. Electronic address: b.guerci@chu-nancy.fr","institution_ids":["https://openalex.org/I90183372"]},{"raw_affiliation_string":"Department of endocrinology, diabetology, and nutrition, Brabois hospital and university of Lorraine, 54500 Vand\u0153uvre-l\u00e8s-Nancy, France","institution_ids":["https://openalex.org/I90183372"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025169113","display_name":"Bernard H. Charbonnel","orcid":"https://orcid.org/0000-0002-2117-9279","observed_orcids":["https://orcid.org/0000-0002-2117-9279"]},"institutions":[{"id":"https://openalex.org/I4405260337","display_name":"Universit\u00e9 de Nantes","ror":"https://ror.org/03kjmz544","country_code":"FR","type":"education","lineage":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Charbonnel","raw_affiliation_strings":["Department of endocrinology, university of Nantes, 44000 Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of endocrinology, university of Nantes, 44000 Nantes, France","institution_ids":["https://openalex.org/I4405260337","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047653403","display_name":"Pierre Gourdy","orcid":"https://orcid.org/0000-0002-5362-3813","observed_orcids":["https://orcid.org/0000-0002-5362-3813"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Gourdy","raw_affiliation_strings":["Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039339457","display_name":"Samy Hadjadj","orcid":"https://orcid.org/0000-0001-7110-6994","observed_orcids":["https://orcid.org/0000-0001-7110-6994"]},"institutions":[{"id":"https://openalex.org/I4210111187","display_name":"Centre Hospitalier Universitaire de Poitiers","ror":"https://ror.org/029s6hd13","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210111187"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S. Hadjadj","raw_affiliation_strings":["Department of diabetology, Poitiers university hospital, 86000 Poitiers, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of diabetology, Poitiers university hospital, 86000 Poitiers, France","institution_ids":["https://openalex.org/I4210111187"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041840200","display_name":"H\u00e9l\u00e8ne P. Hanaire","orcid":"https://orcid.org/0000-0002-8794-8990","observed_orcids":["https://orcid.org/0000-0002-8794-8990"]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Hanaire","raw_affiliation_strings":["Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of diabetology, metabolic diseases and nutrition, Toulouse university hospital, 31059 Toulouse, France","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088350286","display_name":"Michel Marre","orcid":"https://orcid.org/0000-0002-3071-1837","observed_orcids":["https://orcid.org/0000-0002-3071-1837"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Marre","raw_affiliation_strings":["Department of diabetology, endocrinology and nutrition, Bichat hospital, AP-HP, 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of diabetology, endocrinology and nutrition, Bichat hospital, AP-HP, 75018 Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003323204","display_name":"Bruno L Verg\u00e8s","orcid":"https://orcid.org/0000-0001-8957-629X","observed_orcids":["https://orcid.org/0000-0001-8957-629X"]},"institutions":[{"id":"https://openalex.org/I4210116240","display_name":"CHU Dijon Bourgogne","ror":"https://ror.org/0377z4z10","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116240"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Verg\u00e8s","raw_affiliation_strings":["Department of endocrinology-diabetology, University Hospital, 14 rue Gaffarel, 21000 Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of endocrinology-diabetology, University Hospital, 14 rue Gaffarel, 21000 Dijon, France","institution_ids":["https://openalex.org/I4210116240"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5064287355"],"corresponding_institution_ids":["https://openalex.org/I90183372"],"apc_list":{"value":4490,"currency":"USD","value_usd":4490},"apc_paid":{"value":4490,"currency":"USD","value_usd":4490},"fwci":0.6989,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.56431398,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":98},"biblio":{"volume":"45","issue":"6","first_page":"528","last_page":"535"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9800000190734863},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6570000052452087},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9010000228881836},{"id":"https://openalex.org/keywords/insulin-intensification","display_name":"insulin intensification","score":0.6669999957084656},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8399999737739563},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7720000147819519},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.578000009059906},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.7649999856948853},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.753000020980835},{"id":"https://openalex.org/keywords/cost","display_name":"cost","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9481379389762878},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8845358490943909},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6234234571456909},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5845595598220825},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5187468528747559},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.508904218673706},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.5060941576957703},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.49753764271736145},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4857652485370636},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.48040202260017395},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.4795398712158203},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.46111583709716797},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42432254552841187},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.41397473216056824},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.38910552859306335},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3397495448589325},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2909877896308899},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.20086181163787842},{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.18006664514541626},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12805774807929993},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011320","descriptor_name":"Primary Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.diabet.2019.01.006","doi":"https://doi.org/10.1016/j.diabet.2019.01.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabet.2019.01.006","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S1262363619300217?via%3Dihub","source":{"id":"https://openalex.org/S49871393","display_name":"Diabetes & Metabolism","issn_l":"1262-3636","issn":["1262-3636","1878-1780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Diabetes & Metabolism","raw_type":"journal-article"},{"id":"pmid:30677504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30677504","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes & metabolism","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03488985v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-03488985","pdf_url":"https://hal.science/hal-03488985/document","source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes & Metabolism, 2019, 45, pp.528 - 535. ⟨10.1016/j.diabet.2019.01.006⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1016/j.diabet.2019.01.006","doi":"https://doi.org/10.1016/j.diabet.2019.01.006","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.diabet.2019.01.006","pdf_url":"https://www.sciencedirect.com/science/article/am/pii/S1262363619300217?via%3Dihub","source":{"id":"https://openalex.org/S49871393","display_name":"Diabetes & Metabolism","issn_l":"1262-3636","issn":["1262-3636","1878-1780"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Diabetes & Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320314793","display_name":"Intarcia Therapeutics","ror":"https://ror.org/00s0pgz81"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320329624","display_name":"Roche Diabetes Care","ror":null},{"id":"https://openalex.org/F4320332736","display_name":"Novartis Pharma","ror":"https://ror.org/0013shd50"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2912404136.pdf","grobid_xml":"https://content.openalex.org/works/W2912404136.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W906438903","https://openalex.org/W1168171428","https://openalex.org/W1976812315","https://openalex.org/W1978047113","https://openalex.org/W1979422476","https://openalex.org/W2032451413","https://openalex.org/W2036387352","https://openalex.org/W2043900831","https://openalex.org/W2047187313","https://openalex.org/W2048978130","https://openalex.org/W2054568668","https://openalex.org/W2055754603","https://openalex.org/W2059909265","https://openalex.org/W2062098402","https://openalex.org/W2065829166","https://openalex.org/W2085539413","https://openalex.org/W2096416969","https://openalex.org/W2120779228","https://openalex.org/W2124234371","https://openalex.org/W2137352234","https://openalex.org/W2137665561","https://openalex.org/W2139485303","https://openalex.org/W2160088494","https://openalex.org/W2194838818","https://openalex.org/W2199038420","https://openalex.org/W2208246363","https://openalex.org/W2400230962","https://openalex.org/W2425644022","https://openalex.org/W2430926173","https://openalex.org/W2462710388","https://openalex.org/W2471756691","https://openalex.org/W2495635954","https://openalex.org/W2519510391","https://openalex.org/W2533109792","https://openalex.org/W2552473439","https://openalex.org/W2578084918","https://openalex.org/W2585146202","https://openalex.org/W2586129535","https://openalex.org/W2594000342","https://openalex.org/W2595744872","https://openalex.org/W2597203198","https://openalex.org/W2617078900","https://openalex.org/W2620356640","https://openalex.org/W2624755170","https://openalex.org/W2738595939","https://openalex.org/W2743088090","https://openalex.org/W2745199969","https://openalex.org/W2750917994","https://openalex.org/W2751938332","https://openalex.org/W2763255780","https://openalex.org/W2766836053","https://openalex.org/W2770973170","https://openalex.org/W2778234808","https://openalex.org/W2828406404","https://openalex.org/W2894746763","https://openalex.org/W2904088434","https://openalex.org/W6627452231"],"related_works":["https://openalex.org/W7166073576","https://openalex.org/W4210809516","https://openalex.org/W4401399644","https://openalex.org/W2901795399","https://openalex.org/W2952094692","https://openalex.org/W4322495046","https://openalex.org/W4404228453","https://openalex.org/W6920336404","https://openalex.org/W2036764895","https://openalex.org/W2220690107"],"abstract_inverted_index":{"Despite":[0],"the":[1,11,63,135],"availability":[2],"of":[3,7,14,55,109,129,137,165,180,189],"a":[4,92],"large":[5],"number":[6],"therapeutic":[8],"options":[9],"throughout":[10],"world,":[12],"rates":[13,164],"optimal":[15],"glycaemic":[16,46,166],"control":[17,167],"in":[18,29,49,83,113,151],"adult":[19],"patients":[20,84],"with":[21,87,97],"type":[22],"2":[23],"diabetes":[24],"mellitus":[25],"remain":[26],"low.":[27,170],"Delays":[28],"treatment":[30,81,143],"intensification":[31,82],"to":[32,37,44,77,140,162],"insulin":[33,38,79],"and":[34,60,100,116,154,187],"low":[35],"adherence":[36,155],"regimes,":[39],"which":[40],"are":[41,48,95,111,126,191],"well-documented":[42],"contributors":[43],"poor":[45],"control,":[47],"many":[50],"cases":[51],"driven":[52],"by":[53],"fear":[54],"hypoglycaemic":[56,102],"events,":[57],"weight":[58,98],"gain":[59],"injections.":[61,120],"Over":[62],"last":[64],"10":[65],"years,":[66],"injectable":[67],"glucagon-like":[68],"peptide-1":[69],"receptor":[70],"agonists":[71],"(GLP1-RAs)":[72],"have":[73],"emerged":[74],"as":[75,122],"alternatives":[76],"basal":[78],"for":[80],"inadequately":[85],"controlled":[86,124],"oral":[88],"antidiabetic":[89],"drugs.":[90],"As":[91],"class,":[93],"GLP1-RAs":[94],"associated":[96],"loss":[99],"fewer":[101,119],"events":[103],"than":[104],"insulin.":[105],"In":[106,145],"addition,":[107],"some":[108],"them":[110],"available":[112],"once-a-week":[114],"formulations":[115],"therefore":[117],"require":[118],"However,":[121],"randomized":[123],"trials":[125],"not":[127],"representative":[128],"everyday":[130],"practice,":[131],"physicians":[132],"should":[133],"consider":[134],"results":[136],"real-life":[138],"studies":[139],"guide":[141],"their":[142],"decisions.":[144],"this":[146],"review,":[147],"while":[148],"significant":[149],"variations":[150],"efficacy,":[152],"tolerability":[153],"data":[156],"were":[157,169],"noted":[158],"from":[159],"one":[160],"study":[161],"another,":[163],"overall":[168],"Indeed,":[171],"our":[172],"present":[173],"analysis":[174],"has":[175],"suggested":[176],"that":[177],"regular":[178],"re-evaluations":[179],"treatment,":[181],"including":[182],"response,":[183],"tolerability,":[184],"adherence,":[185],"cost":[186],"quality":[188],"life,":[190],"necessary.":[192]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}